Citation Impact
Citing Papers
Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance
2008
Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry
1998 StandoutNobel
The Molecular Genetics of Human Hemoglobin
1984
Rational Design of Intercellular Adhesion Molecule-1 (ICAM-1) Variants for Antagonizing Integrin Lymphocyte Function-associated Antigen-1-dependent Adhesion
2005 StandoutNobel
Differential effects of HDL subpopulations on cellular ABCA1- and SR-BI-mediated cholesterol efflux
2005
Oxazolidinone Structure–Activity Relationships Leading to Linezolid
2003
Thiazolidinediones
2004 Standout
Impaired immune and acute-phase responses in interleukin-6-deficient mice
1994 StandoutNatureNobel
X4 and R5 HIV-1 Have Distinct Post-entry Requirements for Uracil DNA Glycosylase during Infection of Primary Cells
2010 StandoutNobel
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
An evaluation of the molecular clock hypothesis using mammalian DNA sequences
1987
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Metal-Affinity Separations: A New Dimension in Protein Processing
1991 StandoutNobel
Crystal Structure of the Sulfotransferase Domain of Human Heparan SulfateN-Deacetylase/N-Sulfotransferase 1
1999
Macrophages in the Pathogenesis of Atherosclerosis
2011 Standout
Oxazolidinones Mechanism of Action: Inhibition of the First Peptide Bond Formation
2001
Long-Term sensitization training in Aplysia leads to an increase in calreticulin, a major presynaptic calcium-binding protein
1992 StandoutNobel
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
2003 StandoutNature
Mutations Outside the Anisomycin-Binding Site Can Make Ribosomes Drug-Resistant
2008 StandoutNobel
The lymphocyte chemoattractant SDF-1 is a ligand for LESTR/fusin and blocks HIV-1 entry
1996 StandoutNature
The Site of Action of Oxazolidinone Antibiotics in Living Bacteria and in Human Mitochondria
2007
Core Structure of gp41 from the HIV Envelope Glycoprotein
1997 Standout
Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection
1996 Standout
Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-.ANG. resolution
1992
Ribosomal and non‐ribosomal resistance to oxazolidinones: species‐specific idiosyncrasy of ribosomal alterations
2002
Engineered Metal-Binding Proteins: Purification to Protein Folding
1991 StandoutScienceNobel
HIV-1-resistance phenotype conferred by combination of two separate inherited mutations of CCR5 gene
1998 StandoutNobel
Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis
1998 StandoutNature
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Beyond High-Density Lipoprotein Cholesterol Levels
2008
Ribosomal RNA is the target for oxazolidinones, a novel class of translational inhibitors
1999
Interferons as Hormones of Pregnancy*
1992
Mutation rates differ among regions of the mammalian genome
1989 StandoutNature
Oxazolidinones: activity, mode of action, and mechanism of resistance
2004 Standout
Protected nucleotide G2608 in 23S rRNA confers resistance to oxazolidinones in E. coli
2005
Activation of Human Peroxisome Proliferator-Activated Receptor (PPAR) Subtypes by Pioglitazone
2000
Methicillin-Resistant S. aureus Infections among Patients in the Emergency Department
2006 Standout
Progress and challenges in translating the biology of atherosclerosis
2011 StandoutNature
Apolipoprotein AI transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice.
1994
Catalytic Properties of Mutant 23 S Ribosomes Resistant to Oxazolidinones
2003
Cross-linking in the Living Cell Locates the Site of Action of Oxazolidinone Antibiotics
2003
Linezolid update: Stable in vitro activity following more than a decade of clinical use and summary of associated resistance mechanisms
2014
The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1
1996 StandoutNature
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
2011 Standout
Atherosclerosis
2001 Standout
Resistance mutations in 23 S rRNA identify the site of action of the protein synthesis inhibitor linezolid in the ribosomal peptidyl transferase center 1 1Edited by D. E. Draper
1999
Implantation and the placenta: key pieces of the development puzzle
1994 StandoutScience
Antibacterial drug discovery in the resistance era
2016 StandoutNature
Position-independent, high-level expression of the human β-globin gene in transgenic mice
1987 Standout
The Protein Synthesis Inhibitors, Oxazolidinones and Chloramphenicol, Cause Extensive Translational Inaccuracy in Vivo
2002
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
1998 StandoutNature
The structure of LepA, the ribosomal back translocase
2008 StandoutNobel
Oxazolidinone Antibiotics Target the P Site onEscherichiacoliRibosomes
2002
The Oxazolidinone Linezolid Inhibits Initiation of Protein Synthesis in Bacteria
1998
23S rRNA base pair 2057–2611 determines ketolide susceptibility and fitness cost of the macrolide resistance mutation 2058A→G
2005 StandoutNobel
Genetic Models of Human Vascular Disease
1995 StandoutNobel
Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
1993
A gene deletion ending within a complex array of repeated sequences 3' to the human beta-globin gene cluster.
1986 StandoutNobel
Crystal Structure of Human BPI and Two Bound Phospholipids at 2.4 Angstrom Resolution
1997 Science
Nucleotide sequence of 16-kilobase pairs of DNA 5' to the human epsilon-globin gene.
1985 StandoutNobel
Gene expression during preimplantation mouse development.
1992
Functional Role of Type I and Type II Interferons in Antiviral Defense
1994 StandoutScience
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II–III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas
2016 Standout
Rates of nucleotide substitution vary greatly among plant mitochondrial, chloroplast, and nuclear DNAs.
1987 Standout
A DNA motif related to the cAMP-responsive element and an exon-located activator protein-2 binding site in the human tissue-type plasminogen activator gene promoter cooperate in basal expression and convey activation by phorbol ester and cAMP.
1990
Macrophage Reverse Cholesterol Transport
2006
Increased Atherosclerosis in ApoE and LDL Receptor Gene Knock-Out Mice as a Result of Human Cholesteryl Ester Transfer Protein Transgene Expression
1999
Structure and function in rhodopsin: A tetracycline-inducible system in stable mammalian cell lines for high-level expression of opsin mutants
2002
A ChineseGγ+(Aγδβ)0thalassemia deletion: comparison to other deletions in the human β-globin gene cluster and sequence analysis of the breakpoints
1985 StandoutNobel
Unique features of the trophoblast interferons
1991
Linezolid: The First Oxazolidinone Antimicrobial
2003
Oxazolidinone Resistance Mutations in 23S rRNA of Escherichia coli Reveal the Central Region of Domain V as the Primary Site of Drug Action
2000
Linezolid (ZYVOX), the First Member of a Completely New Class of Antibacterial Agents for Treatment of Serious Gram-Positive Infections
2008
Two-dimensional protein crystallization via metal-ion coordination by naturally occurring surface histidines.
1996 StandoutNobel
Resistance to Linezolid: Characterization of Mutations in rRNA and Comparison of Their Occurrences in Vancomycin-Resistant Enterococci
2001
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
1996
Glycobiology: Toward Understanding the Function of Sugars
1996 Standout
Anti-HIV-1 and chemotactic activities of human stromal cell-derived factor 1α (SDF-1α) and SDF-1β are abolished by CD26/dipeptidyl peptidase IV-mediated cleavage
1998 StandoutNobel
Structural basis for cross-resistance to ribosomal PTC antibiotics
2008 StandoutNobel
Genetic Restriction of HIV-1 Infection and Progression to AIDS by a Deletion Allele of the CKR5 Structural Gene
1996 StandoutScience
An approach to oxazolidin-2-ones from the Baylis–Hillman adducts. Formal synthesis of a chloramphenicol derivative
2002
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections
2005
Discovery of Carbohydrate Sulfotransferase Inhibitors from a Kinase-Directed Library
2000 StandoutNobel
The oxazolidinone antibiotics perturb the ribosomal peptidyl-transferase center and effect tRNA positioning
2008
Endothelial cells in physiology and in the pathophysiology of vascular disorders.
1998 Standout
Crystal Structure of the Oxazolidinone Antibiotic Linezolid Bound to the 50S Ribosomal Subunit
2008 StandoutNobel
Severe atherosclerosis in transgenic mice expressing simian cholesteryl ester transfer protein
1993 Nature
The silent carrier allele: β thalassemia without a mutation in the β-globin gene or its immediate flanking regions
1984 StandoutNobel
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Acquisition of a natural resistance gene renders a clinical strain of methicillin‐resistantStaphylococcus aureusresistant to the synthetic antibiotic linezolid
2007
Gene targeting approaches to complex genetic diseases: atherosclerosis and essential hypertension.
1995 StandoutNobel
Challenges of Antibacterial Discovery
2011
Recent Advances in the Baylis−Hillman Reaction and Applications
2003 Standout
Works of K.R. Marotti being referenced
Production of analytical quantities of recombinant proteins in Chinese hamster ovary cells using sodium butyrate to elevate gene expression
1991
Involvement of aspartic and glutamic residues in kringle-2 of tissue-type plasminogen activator in lysine binding, fibrin binding and stimulation of activity as revealed by chemical modification and oligonucleotide-directed mutagenesis
1990
Nucleotide sequence of the cynomolgus monkey apolipoprotein A-I gene and corresponding flanking regions
1992
Resistance mapping and mode of action of a novel class of antibacterial anthranilic acids: evidence for disruption of cell wall biosynthesis
2008
The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin
1997
Molecular cloning, sequence, and expression of cynomolgus monkey cholesteryl ester transfer protein. Inverse correlation between hepatic cholesteryl ester transfer protein mRNA levels and plasma high density lipoprotein levels.
1991
LDHk, a uniquely regulated cryptic lactate dehydrogenase associated with transformation by the Kirsten sarcoma virus.
1981
Centripetal cholesterol flux from extrahepatic organs to the liver is independent of the concentration of high density lipoprotein-cholesterol in plasma.
1996
The primary structure of cynomolgus monkey apolipoprotein a-1 deduced from the cdna sequence: comparison to the human sequence
1986
The role of cholesteryl ester transfer protein in primate apolipoprotein A-I metabolism. Insights from studies with transgenic mice.
1992
Active Human Tissue Plasminogen Activator Secreted from Insect Cells Using a Baculovirus Vector
1988
Protein Kinase C and the Stimulation of Tissue Plasminogen Activator Release from Human Endothelial Cells
1989
Mechanism of action of oxazolidinones: effects of linezolid and eperezolid on translation reactions
1997
Interferon RNA of embryonic origin is expressed transiently during early pregnancy in the ewe.
1988
Apolipoprotein A-I metabolism in cholesteryl ester transfer protein transgenic mice. Insights into the mechanisms responsible for low plasma high density lipoprotein levels.
1994